Home / Resources / Early Clinical resources

早期临床

最新资源

Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals

Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Dizal Pharma

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

精选资源

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Upcoming early clinical webinars

网络研讨会

Phoenix NLME & Pirana：功能强大的 popPK 建模软件可简化定量药理学工作流程

Oct 7, Dec 16 – 11am ET

网络研讨会

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

2025 年 10 月 8 日 – 11 am ET

网络研讨会

监管前沿的机制模型：来自欧洲药品管理局（EMA）对 Simcyp® Simulator 的认证洞见

2025 年 10 月 14 日 – 11am（美东时间）

Latest early clinical blogs

All Early clinical - Blog

药物开发中 PK/PD 建模的机器学习

美国 FDA MIDD 配对试点计划如何帮助赞助商

揭秘临床 DDI 研究：精准测量代谢产物

为何 FDA 批准 omaveloxolone 用于治疗弗里德赖希共济失调症意义重大

细胞疗法开发的主要考虑因素

降低药物开发风险：早期开发中的关键化学、制造和控制（CMC）及基于生理的药代动力学（PBPK）方法

在以下活动中与我们的专家会面

BioTechX EU

2025 年 10 月 6 - 8 日

Phoenix Roadshow 2025 – Copenhagen

2025 年 10 月 7 日

CDISC US 2025

2025 年 10 月 13 - 14 日

All early clinical resources

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Case Study

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Biologics, Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Model Informed Drug Development, Therapeutic Specialties, Conference

Certara 大学：Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Drug Interaction Database (DIDB ®)

Drug-Drug Interactions (DDI), Fact Sheet

临床药理学差距分析最佳实践

Certara Services, Clinical Pharmacology, Modeling and Simulation, Blog

The Impact of Standardized eCRFs from Data Collection to Submission

网络研讨会

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Biologics, Cell and Gene Therapy, Certara Services, Therapeutic Specialties, Press Coverage

What is a Loading Dose?

Certara 产品 - Phoenix，建模和模拟 - PK/PD，博客，知识库

Redefining Every Stage of Investment (RESI) Seed to Exit

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Conference

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Certara Services, Clinical Trials, Drug Development, Project Management, Case Study

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Conference

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Certara Services, Drug Development, Model Informed Drug Development, Modeling and Simulation, Webinar

1
2
3
……
57
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2025 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software